Delayed, sustained-release diltiazem pharmaceutical preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5529790
SERIAL NO

08354378

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A delayed, sustained-release pharmaceutical preparation is provided in which a water-soluble drug core is surrounded by a hydratable diffusion barrier which delays drug release for about 2-10 hours. The hydratable diffusion barrier comprises a film-forming polymer such as an acrylic resin, esterified acrylic resin, or ethyl cellulose or mixtures thereof and an additive which controls the rate of hydration and permeability of the hydratable diffusion barrier selected from the group consisting of lubricants, anionic surfactants, plasticizers, inert water-soluble materials, and mixtures thereof. In the preferred sustained-release pharmaceutical preparation, the film-forming polymer is combined with the additive and coated onto core drug granules to produce a diffusion barrier surrounding the core drug and form microparticles when the drug core is the preferred diltiazem hydrochloride, different coating thicknesses of the diffusion barrier are used to provide a long delay component and a short delay component.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KINAFORM TECHNOLOGY INCP O BOX 826 DAYTON OH 45459

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cobb, Jr Joseph E Columbus, OH 1 59
Eichel, deceased Herman J late of Columbus, OH 2 127
Massmann, Brent D Ballwin, MO 11 583

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation